Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Reduced IGF-1 signaling delays age-associated proteotoxicity in mice.

Cohen E, Paulsson JF, Blinder P, Burstyn-Cohen T, Du D, Estepa G, Adame A, Pham HM, Holzenberger M, Kelly JW, Masliah E, Dillin A.

Cell. 2009 Dec 11;139(6):1157-69. doi: 10.1016/j.cell.2009.11.014.

2.

Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia.

Zemva J, Schubert M.

Curr Diabetes Rev. 2011 Sep;7(5):356-66. Review.

PMID:
21916834
3.
4.
5.

Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.

O'Neill C, Kiely AP, Coakley MF, Manning S, Long-Smith CM.

Biochem Soc Trans. 2012 Aug;40(4):721-7. doi: 10.1042/BST20120080. Review.

PMID:
22817723
6.

Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease.

Giuffrida ML, Tomasello F, Caraci F, Chiechio S, Nicoletti F, Copani A.

Mol Neurobiol. 2012 Dec;46(3):605-13. doi: 10.1007/s12035-012-8313-6. Epub 2012 Aug 12. Review.

PMID:
22886436
7.

Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans.

Barbieri M, Bonafè M, Franceschi C, Paolisso G.

Am J Physiol Endocrinol Metab. 2003 Nov;285(5):E1064-71. Review.

8.

Countering neurodegeneration by reducing the activity of the insulin/IGF signaling pathway: current knowledge and future prospects.

Cohen E.

Exp Gerontol. 2011 Feb-Mar;46(2-3):124-8. doi: 10.1016/j.exger.2010.08.032. Epub 2010 Sep 16. Review.

PMID:
20849948
9.

Igf-I signaling and effects on longevity.

Holzenberger M.

Nestle Nutr Workshop Ser Pediatr Program. 2011;68:237-45; discussion 246-9. doi: 10.1159/000325914. Epub 2011 Oct 3. Review.

PMID:
22044904
10.

Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit?

Puglielli L.

Neurobiol Aging. 2008 Jun;29(6):795-811. Epub 2007 Feb 20. Review.

11.

Minireview: The Complexities of IGF/Insulin Signaling in Aging: Why Flies and Worms Are Not Humans.

Sell C.

Mol Endocrinol. 2015 Aug;29(8):1107-13. doi: 10.1210/me.2015-1074. Epub 2015 Jun 23. Review.

12.

Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights.

Bartke A, Chandrashekar V, Dominici F, Turyn D, Kinney B, Steger R, Kopchick JJ.

Biogerontology. 2003;4(1):1-8. Review.

PMID:
12652183
13.

The many faces of amyloid beta in Alzheimer's disease.

Chiang PK, Lam MA, Luo Y.

Curr Mol Med. 2008 Sep;8(6):580-4. Review.

PMID:
18781964
14.

Caenorhabditis elegans Model for Initial Screening and Mechanistic Evaluation of Potential New Drugs for Aging and Alzheimer’s Disease.

Luo Y, Wu Y, Brown M, Link CD.

In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2009. Chapter 16.

15.

Sex Differences in Longevity and in Responses to Anti-Aging Interventions: A Mini-Review.

Austad SN, Bartke A.

Gerontology. 2015;62(1):40-6. doi: 10.1159/000381472. Epub 2015 May 6. Review.

Supplemental Content

Support Center